Andere Sprachen Hana Pharm Co., Ltd.

Aktien

A293480

KR7293480000

A293480

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 30.04.2024			% 5 Tage	% 1. Jan.
13.300 ^KRW	-.--%		+0,76 %	-4,66 %

2023	Singapur-Aktien kehren ins Plus zurück; Hyphens Pharma steigt um 5% aufgrund eines Deals zur Entwicklung eines Sedierungsmittels in Singapur	MT
2023	Hyphens Pharma entwickelt und vermarktet das Beruhigungsmittel von Hana Pharm in Singapur	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Singapore Shares Return to Green; Hyphens Pharma Rises 5% on Deal to Develop Sedation Drug in Singapore	18.05.23
Hyphens Pharma to Develop, Commercialize Hana Pharm's Sedation Drug in Singapore	18.05.23
Hyphens Pharma Pte. Ltd. Signs an Exclusive Sub-License and Supply Agreement with Hana Pharm Co., Ltd. to Develop and Commercialise Byfavo® 20mg in Singapore	17.05.23
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine	12.04.22
Hana Pharm Receives Market Approval for Byfavo (Remimazolam) in Procedural Sedation in South Korea	31.08.21
Hana Pharm Informs PAION AG About the Launch of Byfavo™ (Remimazolam) for the Use in General Anesthesia in South Korea	07.04.21
Hana Pharm Co., Ltd's Equity Buyback announced on August 19, 2019, has expired.	18.02.20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05.02.20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05.02.20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05.02.20
Hana Pharm Co., Ltd's Equity Buyback announced on August 6, 2019, has expired with 87,239 shares, representing 0.54% for KRW 1,997.13 million.	05.02.20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 9, 2019.	08.01.20
Hana Pharm Co., Ltd's Equity Buyback announced on July 9, 2019, has expired.	08.01.20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 26, 2019.	30.10.19
Hana Pharm Co., Ltd's Equity Buyback announced on July 26, 2019, has expired with 84,312 shares, representing 0.53% for KRW 1,997.08 million.	30.10.19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.	19.08.19
Hana Pharm Co., Ltd authorizes a Buyback Plan.	19.08.19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	06.08.19
Hana Pharm Co., Ltd authorizes a Buyback Plan.	06.08.19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	26.07.19

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hana Pharm Co., Ltd.

Aktien

A293480

KR7293480000

A293480

Andere Sprachen

Filter